$18.77
5.35% yesterday
Nasdaq, Apr 03, 10:00 pm CET
ISIN
IL0011794802
Symbol
CLBT

Cellebrite DI Stock price

$18.77
+0.42 2.29% 1M
+2.22 13.41% 6M
-3.26 14.80% YTD
+7.68 69.25% 1Y
+11.58 161.06% 3Y
+8.52 83.12% 5Y
+8.52 83.12% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-1.06 5.35%
ISIN
IL0011794802
Symbol
CLBT

Key metrics

Market capitalization $4.49b
Enterprise Value $4.06b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 32.83
EV/Sales (TTM) EV/Sales 10.12
P/S ratio (TTM) P/S ratio 11.20
P/B ratio (TTM) P/B ratio 13.10
Revenue growth (TTM) Revenue growth 23.41%
Revenue (TTM) Revenue $401.20m
EBIT (operating result TTM) EBIT $57.13m
Free Cash Flow (TTM) Free Cash Flow $123.61m
Cash position $447.22m
EPS (TTM) EPS $-1.40
P/E forward 62.65
P/S forward 9.28
EV/Sales forward 8.38
Short interest 1.10%
Show more

Is Cellebrite DI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Cellebrite DI Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Cellebrite DI forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Cellebrite DI forecast:

Buy
100%

Financial data from Cellebrite DI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
401 401
23% 23%
100%
- Direct Costs 63 63
18% 18%
16%
339 339
25% 25%
84%
- Selling and Administrative Expenses 172 172
20% 20%
43%
- Research and Development Expense 98 98
17% 17%
25%
68 68
56% 56%
17%
- Depreciation and Amortization 11 11
6% 6%
3%
EBIT (Operating Income) EBIT 57 57
72% 72%
14%
Net Profit -283 -283
249% 249%
-71%

In millions USD.

Don't miss a Thing! We will send you all news about Cellebrite DI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cellebrite DI Stock News

Neutral
GlobeNewsWire
3 days ago
The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees
Neutral
GlobeNewsWire
17 days ago
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”).
Positive
The Motley Fool
about 2 months ago
In this video, Anand Chokkavelu, Travis Hoium, and Lou Whiteman discuss Cellebrite (CLBT -5.53%), a key player in digital forensics for law enforcement. They provide ratings and insights on its growth potential, management, and financials, helping you decide if this stock is a worthy investment.
More Cellebrite DI News

Company Profile

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

Head office Israel
CEO Thomas Hogan
Employees 1,167
Founded 1999
Website www.cellebrite.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today